The Patent Finder

Terms ending in 2038

Valneva SE

Every in-force patent on Valneva SE's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,331,084Multivalent Ospa Polypeptides and Methods and Uses Relating Thereto
In force
 · High confidence
Valneva Austria GmbHIn forceHigh confidence
US 11,357,846Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus CHIKV-DELTA5NP3
In force
 · High confidence
Valneva SEIn forceHigh confidence
US 11,484,587Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus CHIKV-DELTA5NSP3
In force
 · High confidence
Valneva SEIn forceHigh confidence
US 12,011,477Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus CHIKV-DELTA5NSP3
In force
 · High confidence
Valneva SEIn forceHigh confidence
US 12,564,625Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus CHIKV-DELTA5NSP3
In force
 · High confidence
Valneva SEIn forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited